Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

CELLCEPT 500 MG TABLET

Mycophenolate Mofetil
$17.3898per EA
High Outlier

Strength

500 mg/1

Manufacturer

Genentech, Inc.

NDC

00004026043

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

MYCOPHENOLATE MOFETIL

Approval Type

New Drug (NDA)

FDA Application

NDA050723

On Market Since

6/19/1997

Pharmacological Classes

Antimetabolite Immunosuppressant

Price History

1W

0.0%

1M

+0.3%

3M

+0.4%

6M

+0.6%

1Y

+0.5%

3Y

+0.5%

5Y

+0.5%

All

+48.5%

Generic Alternatives

Save up to 98%

8 alternatives • Same active ingredient

MYCOPHENOLATE 500 MG TABLET
Generic
00781517501•Sandoz Inc.
$0.2698
Save 98%
MYCOPHENOLATE 500 MG TABLET
Generic
67877022501•Ascend Laboratories, LLC
$0.2698
Save 98%
MYCOPHENOLATE 500 MG TABLET
Generic
59651063801•Aurobindo Pharma Limited
$0.2698
Save 98%
MYCOPHENOLATE 500 MG TABLET
Generic
50268055815•AvPAK
$0.2698
Save 98%
MYCOPHENOLATE 500 MG TABLET
Generic
31722087905•Camber Pharmaceuticals Inc.
$0.2698
Save 98%
MYCOPHENOLATE 500 MG TABLET
Generic
60687043801•American Health Packaging
$0.2698
Save 98%
MYCOPHENOLATE 500 MG TABLET
Generic
00054016625•Hikma Pharmaceuticals USA Inc.
$0.2698
Save 98%
CELLCEPT 500 MG TABLET
Brand
00004026001•Genentech, Inc.
$17.3898

Related Drugs

Same classification

MYFORTIC 180 MG TABLET
Brand
00078038566•Novartis Pharmaceuticals Corporation
$7.3438
per EA
MYFORTIC 360 MG TABLET
Brand
00078038666•Novartis Pharmaceuticals Corporation
$14.6414
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy